Bli medlem
Bli medlem

Du är här

2016-03-10

Nexam Chemical: Nexam Chemical intends to execute a private placement of shares to Swedish and international institutional investors

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY,
IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA,
SINGAPORE, SOUTH AFRICA OR NEW ZEALAND OR IN ANY JURISDICTION IN
WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF ANY SECURITIES OF
NEXAM CHEMICAL.

Nexam Chemical Holding AB (publ) today announces that it intends to
execute a private placement of Nexam Chemical shares to a limited
number of Swedish and international institutional investors.

The price for the shares will be determined through a book-building
procedure initiated at 5.31pm CET on 10 March 2016. Pricing and
allocation of the private placement is expected to take place before
NASDAQ OMX First North opens at 9:00am CET on 11 March 2016. The
total number of shares to be offered in the private placement will be
determined in the book-building process. The proceeds from the
private placement are intended to finance the continued expansion of
the company.

The private placement is conditional upon that the Board of Directors
of Nexam Chemical, following close of the book-building process,
resolves to issue new Nexam Chemical shares pursuant to the
authorization given by the annual general meeting held on 12 May
2015.

Danske Bank is acting as sole lead manager and bookrunner of the
private placement. Ashurst is legal adviser to Danske Bank and
Setterwalls is legal adviser to Nexam Chemical.

Note: This press release has been translated from Swedish. The Swedish
text shall govern for all purposes and prevail in case of any
discrepancy with the English version.

For further information please contact:

Lennart Holm, Chairman of the Board, +46-706 30 85 62,
lennart.holm@nexamchemical.com

Anders Spetz, CEO, +46-703 47 97 00, anders.spetz@nexamchemical.com

____________________________________________________________________________

About Nexam Chemical

Nexam Chemical develops technology and products that make it possible
to significantly improve the production process and properties of
most types of plastics in a cost-effective manner and with retained
production technology. The improved properties include strength,
toughness, temperature and chemical resistance as well as service
life. The improvements in properties that can be achieved by using
Nexam Chemical's technology make it possible to replace metals and
other heavier or more expensive materials with plastics in a number
of applications. In applications where plastic is already used, Nexam
Chemicals products can improve the manufacturing process, reducing
material use and enable more environmental friendly alternatives.
Example of commercial applications: pipe manufacturing, foam
production and high-performance plastics. More information about the
business will be found on www.nexamchemical.com
(http://file///\\TELLUS\styrelsen\A.%20Pressmeddelanden%20och%20nyheter\Pressmeddelanden\Eng\www.nexamchemical.com).
The company's Certified Adviser is Remium Nordic AB.

This is information required to be disclosed by Nexam Chemical Holding
AB (publ) pursuant to the First North Nordic Rulebook. This
information was released for publication on 10 March 2016, at 5:31pm
CET.

IMPORTANT INFORMATION
The release, publication or distribution of this press release in
certain jurisdictions may be restricted. This press release does not
constitute an offer of, or an invitation to purchase or subscribe
for, any securities of Nexam Chemical in any jurisdiction.

This press release does not constitute or form part of an offer or
solicitation to purchase or subscribe for securities in the United
States. The securities referred to herein have not been and will not
be registered under the US Securities Act of 1933, as amended (the
"US Securities Act") or under the securities laws of any state or
other jurisdiction of the United States and may not be offered or
sold in the United States absent registration except pursuant to an
exemption from, or in a transaction not subject to, the registration
requirements under the US Securities Act and in compliance with any
applicable laws of any state or other jurisdiction of the United
States. There will be no public offering of the securities in the
United States. Copies of this announcement should not be made in and
may not be distributed or sent into the United States, Australia,
Hong Kong, Japan, Canada, Singapore, South Africa or New Zealand.

This press release is not a prospectus for the purposes of Directive
2003/71/EC (such Directive, together with any applicable implementing
measures under such Directive in the relevant home Member State, the
"Prospectus Directive"). Nexam Chemical has not authorized any offer
to the public of shares or rights in any Member State of the European
Economic Area and no prospectus or other offering document has been
or will be prepared in connection with the Private Placement. With
respect to each Member State of the European Economic Area and which
has implemented the Prospectus Directive (each, a "Relevant Member
State"), no action has been undertaken to date to make an offer to
the public of shares or rights requiring a publication of a
prospectus in any Relevant Member State. In any Relevant Member State
this communication is only addressed to and is only directed at
qualified investors in that Member State within the meaning of the
Prospectus Directive.

This press release is only being distributed to and is only directed
at (i) persons who are outside the United Kingdom or (ii) to
investment professionals falling within Article 19(5) of the
Financial Services and Markets Act 2000 (Financial Promotion Order
2005) (the "Order") or (iii) high net worth companies, and other
persons to whom it may lawfully be communicated, falling within
Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii)
and (iii) above together being referred to as "relevant persons").
The securities are only available to, and any invitation, offer or
agreement to subscribe, purchase or otherwise acquire such securities
will be engaged in only with relevant persons. Any person who is not
a relevant person should not act or rely on this document or any of
its contents.

The Bookrunner is acting exclusively for Nexam Chemical and no one
else in connection with the Private Placement. The Bookrunner will
not regard any other person (whether or not a recipient of this press
release) as its client in relation to the Private Placement and will
not be responsible to anyone other than Nexam Chemical for providing
the protections afforded to their clients nor for giving advice in
relation to the Private Placement or any transaction or arrangement
referred to herein. No representation or warranty, express or
implied, is made by the Bookrunner as to the accuracy, completeness
or verification of the information set forth in this press release,
and nothing contained in this press release is, or shall be relied
upon as, a promise or representation in this respect, whether as to
the past or the future. The Bookrunner assumes no responsibility for
its accuracy, completeness or verification and, accordingly,
disclaim, to the fullest extent permitted by applicable law, any and
all liability which they might otherwise be found to have in respect
of this press release or any such statement.

The Private Placement will be subject to conditions and termination
events, including those which are customary for such offerings. The
Bookrunner reserves the right to exercise or refrain from exercising
its rights in relation to the fulfillment or otherwise of any such
conditions or the occurrence of any termination event in such manner
as it may determine in its absolute discretion. Any investors in the
Private Placement will be deemed to acknowledge that any offering of
shares hence may not be completed and that neither the company nor
the Bookrunner in such event shall have any liability to the
investors. Any investors in the Private Placement will further be
deemed to acknowledge (i) the information in this press release, (ii)
that the investors are not relying (for purposes of making any
investment decision or otherwise) upon any advice, counsel or
representations (whether written or oral) of the company, the
Bookrunner or any of their respective affiliates or any non-public
information, and (iii) that they have consulted with their own legal,
regulatory, tax, business, investment, financial, and accounting
advisers to the extent they have deemed necessary, and they have made
their own investment decisions based upon their own judgment and upon
any advice from such advisers as they have deemed necessary. Any
investors are also expected to enter into a customary application
agreement. The company has not given, and the investors have not
received from the company, any non-public information in connection
with the Private Placement.

This press release may contain "forward-looking statements", which are
statements related to future events. In this context, forward-looking
statements often address Nexam Chemical's expected future business
and financial performance, and often contain words such as "expect",
"anticipate", "intend", "plan", "believe", "seek", or "will".
Forward-looking statements by their nature address matters that are,
to different degrees, uncertain and can be influenced by many
factors, including the behavior of financial markets, fluctuations in
interest and exchange rates, commodity and equity prices and the
value of financial assets; the impact of regulation and regulatory,
investigative and legal actions; strategic actions; and numerous
other matters of national, regional and global scale, including those
of a political, economic, business and competitive nature. These
factors may cause Nexam Chemical's actual future results to be
materially different than those expressed in its forward-looking
statements. Nexam Chemical does not undertake to update its
forward-looking statements.

-----------------------------------------------------------
http://news.cision.com/nexam-chemical/r/nexam-chemical-intends-to-execut...
http://mb.cision.com/Main/6364/9932634/487465.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.